» Articles » PMID: 11122246

Hepatitis C Virus (HCV) in Lymphocyte Subsets and in B Lymphocytes Expressing Rheumatoid Factor Cross-reacting Idiotype in Type II Mixed Cryoglobulinaemia

Overview
Date 2000 Dec 21
PMID 11122246
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The IgMk rheumatoid factors (RF) of type II mixed cryoglobulinaemia (MC) react, in 95% of cases, with MoAbs against the cross-reactive idiotypes (CRI) Cc1 or Lc1 (corresponding to the products of the VH1 and VH4 genes). MC is closely associated with HCV infection, a virus which infects lymphocytes and may replicate in B cells. It has been suggested that HCV may induce clonal selection of B cells producing monoclonal IgMk RF in type II MC. To verify whether HCV is enriched in B cells, and in the subsets expressing Cc1 and Lc1 CRI, we studied peripheral blood lymphocytes from eight patients with MC and HCV RNA-positive sera. Seven patients had RF reacting with anti-Cc1, the other with anti-Lc1 CRI. Total lymphocytes, T cells, B cells, and Cc1+ or Lc1+, Cc1- or Lc1- B cells were purified using MoAb-coated magnetic beads. Lymphocyte subsets were then diluted to give a range of 1 x 106-1 x 103 cells and tested for HCV RNA by reverse transcriptase-polymerase chain reaction. HCV was found exclusively in B cells in seven out of eight patients. In three patients HCV was enriched in the Cc1+ cells. In one of these patients, HCV was found exclusively in Cc1+ cells, with Cc1- cells being HCV-. The data indicate that B cells from type II MC patients are almost constantly infected by HCV. In selected cases, B cell subsets expressing IgMk RF CRI are the prevalent cell type infected by HCV. Our data suggest HCV involvement in B cell dysregulation leading to cryoprecipitable IgMk RF production.

Citing Articles

Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Yu Y, Shi X, Wang X, Zhang P, Bai O, Li Y Cell Biosci. 2022; 12(1):30.

PMID: 35279210 PMC: 8917635. DOI: 10.1186/s13578-022-00763-0.


Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?.

Bunchorntavakul C, Mitrani R, Reddy K J Clin Exp Hepatol. 2018; 8(1):81-94.

PMID: 29743799 PMC: 5938331. DOI: 10.1016/j.jceh.2017.11.012.


Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.

Park G, Kim D, Park S, Lee H, Kim J, Kim Y Int J Mol Med. 2015; 36(6):1464-78.

PMID: 26498453 PMC: 4678167. DOI: 10.3892/ijmm.2015.2372.


Autoimmune manifestations in viral hepatitis.

Vergani D, Mieli-Vergani G Semin Immunopathol. 2012; 35(1):73-85.

PMID: 23010889 DOI: 10.1007/s00281-012-0328-6.


The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.

Bumbea H, Vladareanu A, Vintilescu A, Radesi S, Ciufu C, Onisai M J Med Life. 2012; 4(3):256-63.

PMID: 22567048 PMC: 3168828.


References
1.
Franzin F, Efremov D, Pozzato G, Tulissi P, Batista F, Burrone O . Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol. 1995; 90(3):548-52. DOI: 10.1111/j.1365-2141.1995.tb05582.x. View

2.
Muller H, Kallinowski B, Solbach C, Theilmann L, Goeser T, Pfaff E . B-lymphocytes are predominantly involved in viral propagation of hepatitis C virus (HCV). Arch Virol Suppl. 1994; 9:307-16. DOI: 10.1007/978-3-7091-9326-6_31. View

3.
Agnello V . The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol. 1997; 19(1):111-29. DOI: 10.1007/BF00945029. View

4.
Donato F, Tagger A, Chiesa R, Ribero M, Tomasoni V, Fasola M . Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology. 1997; 26(3):579-84. DOI: 10.1002/hep.510260308. View

5.
Muratori L, Gibellini D, Lenzi M, Cataleta M, Muratori P, Morelli M . Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood. 1996; 88(7):2768-74. View